Status:
UNKNOWN
Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device Insertion
Lead Sponsor:
Aswan University Hospital
Conditions:
IUCD Complication
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
To compare the effect of vaginal dinoprostone versus vaginal misoprostol and Isonicotinic Acid Hydrazide administered before the copper intrauterine device(IUD) insertion in reducing IUD inertion pain...
Detailed Description
Long-acting reversible contraception methods are highly effective methods for reduction of the unplanned pregnancy rate worldwide. The intrauterine device is a single procedure that provides reliable,...
Eligibility Criteria
Inclusion
- nulliparous women requesting copper IUD insertion
Exclusion
- pregnancy,
- Parous women,
- contraindications or allergy to dinoprostone or misoprostol,contraindication to IUD insertion,
- untreated active cervicitis or vaginitis,
- undiagnosed abnormal uterine bleeding
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04505943
Start Date
September 1 2020
End Date
September 30 2021
Last Update
August 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University Hospital
Aswān, Egypt, 81528